| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5912013 | TAKEDA PHARMS USA | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
Jun, 2016
(7 years ago) | |
Carbatrol is owned by Takeda Pharms Usa.
Carbatrol contains Carbamazepine.
Carbatrol has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Carbatrol are:
- US5912013
Carbatrol was authorised for market use on 30 September, 1997.
Carbatrol is available in capsule, extended release;oral dosage forms.
Carbatrol can be used as neurological and other disorders (treatment of epilepsy, bid oral dosing).
The generics of Carbatrol are possible to be released after 15 June, 2016.
Drugs and Companies using CARBAMAZEPINE ingredient
Market Authorisation Date: 30 September, 1997
Treatment: Neurological and other disorders (treatment of epilepsy, bid oral dosing)
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
How can I launch a generic of CARBATROL before it's drug patent expiration?
More Information on Dosage
CARBATROL family patents
